Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: Berg, Forma/Celgene, Intarcia, & More 04/04/14 Boston
Backed By a Billionaire, Berg Pharma Aims to Speed Drugmaking 04/02/14 Boston
Forma Gets $225M More, And a Potential Buyout, From Celgene 04/01/14 Boston
Ann Arbor’s 3D Biomatrix Clears Final Hurdle to Patent 02/06/14 Detroit
With Record $275M Gift, Sanford-Burnham Unveils New 10-Year Plan 01/28/14 San Diego
First Startup from Avalon-GSK Deal Raises $10M for Celiac Disease 11/22/13 San Diego
X-Chem, Aiming For Tough-to-Drug Targets, Cuts Deal With AstraZeneca 09/25/13 Boston
Numerate Trains Its Drug Design Platform On Huntington’s Disease 09/24/13 San Francisco
Adimab Teams Up With Celgene, Innovent, in Latest Partnership Deals 08/20/13 Boston
Adimab Turns Cash Flow Positive With GSK, Biogen Tech Transfer Deals 07/26/13 Boston
Effector Therapeutics Raises $45M to Prove New Concept in Cancer 05/21/13 San Diego
Using Bioprinting Technology, San Diego’s Organovo Makes 3D Tissue 04/23/13 San Diego
Organovo Joins with OHSU to Bio-Engineer Cancer Tissue for Drug R&D 01/30/13 San Diego
Xconomist of the Week: Alexis Borisy Still Likes Early Stage Biotechs 12/20/12 Boston
U-M’s New Drug Discovery Center to Commercialize Research 09/05/12 Detroit
Xconomist of the Week: John Reed on Sanford-Burnham’s Drug Pipeline 08/03/12 San Diego
A Sweet Deal: How Amira Reinvented Itself as a Drug Discovery Engine 12/23/11 San Diego
EnVivo, Biogen, Momenta, & Other Boston-Area Life Sciences Newsmakers 12/09/11 Boston
Sanford-Burnham Joins Fold at Pfizer’s Centers for Therapeutic Innovation 11/03/11 San Diego
GSK and Unilever Among Early Adopters of BioLeap’s Technology for Creating New Molecules 08/23/11 New York
Organovo’s Bio-Printing Technology Yields Unanticipated Revenue from Pharma Partners 07/13/11 San Diego
3D Biomatrix Hopes To Break Into Drug Discovery Market With 3D Testing Devices 07/07/11 Detroit
Nimbus, Seeded by Bill Gates, Raises $24 Million For Computer-Aided Drug Discovery 06/28/11 Boston
Constellation Pharma Raises $15M for Epigenetic Drugs 06/06/11 Boston
Former Pfizer R&D Chief Urges Big Pharma To Go Small 04/21/11 Detroit
From Human Tissue Supplier to R&D Contractor to BioBank Builder, Asterand Seeks Its Future 03/16/11 Detroit
Entrega Emerges From Enlight 01/10/11 Boston
Testing Experimental Drugs in Combination – A New Trend 12/22/10 San Diego
Taking a VC Approach to Charity, Greylock Veteran’s Alzheimer’s Research Foundation “Dares to Be Great” 08/25/10 Boston
Aileron Inks Deal with Roche, Worth Up to $1.1B, to Develop Stapled Peptide Drugs 08/24/10 Boston
Page 1 of 2 next page »